[go: up one dir, main page]

MX2018003037A - Produccion de oligosacaridos de leche humana en huespedes microbianos con importacion/exportacion diseñada. - Google Patents

Produccion de oligosacaridos de leche humana en huespedes microbianos con importacion/exportacion diseñada.

Info

Publication number
MX2018003037A
MX2018003037A MX2018003037A MX2018003037A MX2018003037A MX 2018003037 A MX2018003037 A MX 2018003037A MX 2018003037 A MX2018003037 A MX 2018003037A MX 2018003037 A MX2018003037 A MX 2018003037A MX 2018003037 A MX2018003037 A MX 2018003037A
Authority
MX
Mexico
Prior art keywords
export
production
oligosacarids
guests
microbial
Prior art date
Application number
MX2018003037A
Other languages
English (en)
Other versions
MX391225B (es
Inventor
Jennewein Stefan
Wartenberg Dirk
Original Assignee
Jennewein Biotechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jennewein Biotechnologie Gmbh filed Critical Jennewein Biotechnologie Gmbh
Publication of MX2018003037A publication Critical patent/MX2018003037A/es
Publication of MX391225B publication Critical patent/MX391225B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1048—Glycosyltransferases (2.4)
    • C12N9/1051—Hexosyltransferases (2.4.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y204/00—Glycosyltransferases (2.4)
    • C12Y204/01—Hexosyltransferases (2.4.1)
    • C12Y204/01146—Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase (2.4.1.146)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Communicable Diseases (AREA)

Abstract

La presente invención se refiere a métodos para la producción de oligosacáridos en células hospederas genéticamente modificadas, así como a las células hospederas genéticamente modificadas en los métodos. La célula hospedera genéticamente modificada comprende al menos una glicosiltransferasa recombinante y al menos una secuencia de ácido nucleico que codifica una proteína que permite la exportación del oligosacárido.
MX2018003037A 2015-09-12 2016-09-12 Produccion de oligosacaridos de leche humana en huespedes microbianos con importacion/exportacion diseñada. MX391225B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15184968.4A EP3141610A1 (en) 2015-09-12 2015-09-12 Production of human milk oligosaccharides in microbial hosts with engineered import / export
PCT/EP2016/071420 WO2017042382A1 (en) 2015-09-12 2016-09-12 Production of human milk oligosaccharides in microbial hosts with engineered import / export

Publications (2)

Publication Number Publication Date
MX2018003037A true MX2018003037A (es) 2019-01-10
MX391225B MX391225B (es) 2025-03-21

Family

ID=54148344

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2018003037A MX391225B (es) 2015-09-12 2016-09-12 Produccion de oligosacaridos de leche humana en huespedes microbianos con importacion/exportacion diseñada.
MX2022003994A MX2022003994A (es) 2015-09-12 2018-03-09 Produccion de oligosacaridos de leche humana en huespedes microbianos con importacion/exportacion dise?ada.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2022003994A MX2022003994A (es) 2015-09-12 2018-03-09 Produccion de oligosacaridos de leche humana en huespedes microbianos con importacion/exportacion dise?ada.

Country Status (11)

Country Link
US (4) US11046985B2 (es)
EP (2) EP3141610A1 (es)
JP (4) JP7069007B2 (es)
KR (2) KR102700050B1 (es)
CN (1) CN108026556B (es)
AU (1) AU2016319304B2 (es)
BR (1) BR112018004725A2 (es)
MX (2) MX391225B (es)
PH (1) PH12018550020A1 (es)
RU (1) RU2763170C2 (es)
WO (1) WO2017042382A1 (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2896628B1 (en) 2014-01-20 2018-09-19 Jennewein Biotechnologie GmbH Process for efficient purification of neutral human milk oligosaccharides (HMOs) from microbial fermentation
EP3141610A1 (en) * 2015-09-12 2017-03-15 Jennewein Biotechnologie GmbH Production of human milk oligosaccharides in microbial hosts with engineered import / export
AU2018305183A1 (en) * 2017-07-26 2020-02-13 Chr. Hansen HMO GmbH Sialyltransferases and their use in producing sialylated oligosaccharides
US12071614B2 (en) 2018-04-23 2024-08-27 Inbiose N.V. Increasing activity of 2′fucosyllactose transporters endogenous to microbial cells
EP3790413A1 (en) 2018-05-07 2021-03-17 Jennewein Biotechnologie GmbH A SIMPLE METHOD FOR THE PURIFICATION OF LACTO-N-NEOTETRAOSE (LNnT) FROM CARBOHYDRATES OBTAINED BY MICROBIAL FERMENTATION
CN109554385B (zh) * 2018-07-24 2022-04-12 石家庄葛兰德生物科技有限公司 一种基因工程菌制备2-岩藻糖基乳糖的方法
CN109034378B (zh) * 2018-09-04 2023-03-31 腾讯科技（深圳）有限公司 神经网络的网络表示生成方法、装置、存储介质和设备
WO2020072617A1 (en) * 2018-10-02 2020-04-09 Zimitech, Inc. Use of substrate importers for the export of oligosaccharides
CN109370948B (zh) * 2018-11-26 2020-08-04 江南大学 一株高产6-磷酸-β-半乳糖苷酶的乳酸乳球菌及其应用
CN109825465B (zh) * 2019-02-27 2021-11-12 光明乳业股份有限公司 基于平衡udp-糖供给合成乳酰-n-新四糖的重组枯草芽孢杆菌及其构建方法与应用
CN109735480B (zh) * 2019-02-27 2021-11-12 光明乳业股份有限公司 一种合成乳酰-n-新四糖的重组枯草芽孢杆菌及其构建方法与应用
BR112021019450A2 (pt) * 2019-04-02 2021-11-30 Spiber Inc Método para produzir proteína recombinante
EP3751003A1 (en) 2019-06-12 2020-12-16 Jennewein Biotechnologie GmbH Production of fucosylated oligosaccharides in bacillus
CA3147502A1 (en) * 2019-07-19 2021-01-28 Inbiose N.V. Production of fucosyllactose in host cells
JP2022544267A (ja) * 2019-08-13 2022-10-17 アミリス，インコーポレイティド 酵母でのオリゴ糖産生の改善
EP3789495A1 (en) 2019-09-03 2021-03-10 Jennewein Biotechnologie GmbH Production of sialylated oligosaccharides in bacillus cells
WO2021019104A2 (en) 2019-09-18 2021-02-04 Basf Se A production host for producing human milk oligosaccharides
US12364721B2 (en) 2019-09-24 2025-07-22 Prolacta Bioscience, Inc. Compositions and methods for treatment of inflammatory and immune diseases
CA3157881A1 (en) * 2019-10-14 2021-04-22 Inbiose N.V. Production of bioproduct in a host cell
WO2021123113A1 (en) * 2019-12-18 2021-06-24 Inbiose N.V. Production of sialylated oligosaccharide in host cells
EP3848471A1 (en) * 2020-01-10 2021-07-14 Chr. Hansen HMO GmbH Sequential fermentative production of oligosaccharides
EP4093747A1 (en) 2020-01-23 2022-11-30 Glycom A/S Hmo production
US20230109937A1 (en) * 2020-01-23 2023-04-13 Glycom A/S New major facilitator superfamily (mfs) protein (fred) in hmo production
WO2021148610A1 (en) * 2020-01-23 2021-07-29 Glycom A/S Hmo production
BR112022014423A2 (pt) * 2020-01-23 2022-09-27 Glycom As Produção de hmo
US20230193335A1 (en) * 2020-01-23 2023-06-22 Glycom A/S Hmo production
US20230183767A1 (en) * 2020-04-01 2023-06-15 Zimitech, Inc. Methods for production of oligosaccharides
EP3929300A1 (en) 2020-06-26 2021-12-29 Chr. Hansen HMO GmbH Improved export of oligosaccharides from bacterial cells
IL300573A (en) 2020-08-14 2023-04-01 Prolacta Bioscience Inc Breast milk oligosaccharide compositions for use with bacteriotherapy
CN111979168B (zh) * 2020-08-17 2022-07-22 江南大学 一种提高乳酰-n-三糖ii产量的基因工程菌及生产方法
WO2022133093A1 (en) * 2020-12-17 2022-06-23 Amyris, Inc. MODIFIED β-1, 3-N-ACETYLGLUCOSAMINYLTRANSFERASE POLYPEPTIDES
DK180952B1 (en) 2020-12-22 2022-08-10 Glycom As A dfl-producing strain
WO2022155201A1 (en) 2021-01-12 2022-07-21 Prolacta Bioscience, Inc. Synbiotic treatment regimens
JP2024503868A (ja) * 2021-01-17 2024-01-29 ジェノマティカ， インコーポレイテッド アミド化合物を生成する方法および組成物
TW202246496A (zh) * 2021-01-20 2022-12-01 比利時商因比奥斯公司 在宿主細胞中產生包含ln3作為核心結構的寡醣
JP2024505126A (ja) * 2021-01-22 2024-02-05 グリコム・アクティーゼルスカブ シアル酸付加ｈｍｏの産生における新規の主要ファシリテータースーパーファミリー（ｍｆｓ）タンパク質（ｆｒｅｄ）
US20240110212A1 (en) * 2021-02-08 2024-04-04 Kyowa Hakko Bio Co., Ltd. Protein having fucose-containing sugar transporting activity, and method for producing fucose-containing sugar
CN118813659A (zh) * 2021-04-14 2024-10-22 上海凯赛生物技术股份有限公司 用于发酵生产1,5-戊二胺的重组dna、菌株及其用途
CN117157396A (zh) * 2021-04-16 2023-12-01 因比奥斯公司 唾液酸化的二糖和/或寡糖的细胞生产
WO2022243310A1 (en) 2021-05-17 2022-11-24 Dsm Ip Assets B.V. Novel technology to enable sucrose utilization in strains for biosyntetic production
DK181242B1 (en) 2021-05-17 2023-05-30 Dsm Ip Assets Bv GENETICALLY ENGINEERED CELLS COMPRISING A RECOMBINANT NUCLEIC ACID SEQUNCE ENCODING AN α-1,2-FUCOSYLTRANSFERASE CAPABLE OF PRODUCING LNFP-I, NUCLEIC ACID SEQUENCES ENCODING SAME AND METHODS FOR USE OF SAME
DK181497B1 (en) 2021-05-17 2024-03-12 Dsm Ip Assets Bv ENHANCING FORMATION OF THE HMOS LNT AND/OR LNnT BY MODIFYING LACTOSE IMPORT IN THE CELL
DK181310B1 (en) * 2021-05-17 2023-08-08 Dsm Ip Assets Bv Cell factories for lnt-ii production
PH12023553158A1 (en) 2021-05-20 2024-03-11 Chr Hansen As Sequential fermentative production of oligosaccharides
CN113684163B (zh) * 2021-08-04 2023-07-25 江南大学 一种提高乳酰-n-四糖产量的基因工程菌及其生产方法
CN113684164B (zh) * 2021-08-06 2023-08-25 江南大学 一种高产乳酰-n-新四糖的微生物的构建方法及应用
US20250051814A1 (en) * 2021-12-21 2025-02-13 Kyowa Hakko Bio Co., Ltd. Method for producing sugar including lacto-n-triose ii as core trisaccharide and method for producing crystals of said sugar
DK181683B1 (en) * 2022-03-02 2024-09-20 Dsm Ip Assets Bv Cells exprssing new sialyltransferases for in vivo synthesis of lst-a, methods using same and constructs encoding said sialyltransferases
WO2023168441A1 (en) * 2022-03-04 2023-09-07 The Regents Of The University Of California Production of milk oligosaccharides in plants
CN116042562B (zh) * 2022-03-11 2023-10-20 山东恒鲁生物科技有限公司 重组酵母菌及其应用
CN117003803A (zh) 2022-05-07 2023-11-07 山东恒鲁生物科技有限公司 一种三糖的新晶型
US20250313874A1 (en) * 2022-05-11 2025-10-09 Advanced Protein Technologies Corp. Method for producing lacto-n-tetraose and lacto-n-neotetraose using corynebacterium glutamicum
CN115873051B (zh) 2022-05-17 2024-06-25 山东恒鲁生物科技有限公司 三糖的新晶型
DK181765B1 (en) 2022-07-15 2024-12-04 Dsm Ip Assets Bv Cells expressing new fucosyltransferases for in vivo synthesis of lnfp-iii, and methods and uses of same
CN120418276A (zh) * 2022-10-25 2025-08-01 因比奥斯公司 关于乳-n-三糖的糖输入体
CN119432793A (zh) * 2022-11-21 2025-02-14 山东恒鲁生物科技有限公司 合成HMOs的成熟多肽序列及应用
WO2024128827A1 (ko) * 2022-12-14 2024-06-20 (주)에이피테크놀로지 코리네박테리움 글루타미쿰을 이용한 락토-n-푸코펜타오스의 생산 방법
WO2024130119A2 (en) 2022-12-16 2024-06-20 Prolacta Bioscience, Inc. Synbiotic compositions for short chain fatty acid production
WO2025047866A1 (ja) * 2023-08-30 2025-03-06 キリンホールディングス株式会社 遺伝子改変微生物、及びオリゴ糖の製造方法
WO2025047865A1 (ja) * 2023-08-30 2025-03-06 キリンホールディングス株式会社 遺伝子改変微生物、及びオリゴ糖の製造方法
DK182227B1 (en) 2023-10-17 2025-12-18 Dsm Ip Assets Bv Genetically engineered cells comprising new fucosyltransferases for in vivo synthesis of complex fucosylated human milk oligosaccharides mixtures comprising lnfp-vi, methods using the same, and uses of new fucosyltransferases thereof.
CN119736222A (zh) * 2024-11-08 2025-04-01 嘉必优生物技术（武汉）股份有限公司 生产乳糖-n-新四糖的基因工程菌及其构建方法与应用
CN119752754A (zh) * 2024-12-30 2025-04-04 北京华熙荣熙生物技术研究有限公司 一种制备人乳寡糖的工程菌及其应用
CN120758436B (zh) * 2025-09-10 2025-12-26 深圳市朗坤科技股份有限公司 一种提升乳糖-n-四糖产量的重组大肠杆菌及其构建与应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2796082B1 (fr) * 1999-07-07 2003-06-27 Centre Nat Rech Scient Procede de production d'oligosaccharides
DK1625211T3 (en) * 2003-05-22 2015-02-23 Danisco Us Inc Metabolic MANIPULATED BACTERIA STRAINS THAT ARE NON-FUNCTIONAL endogenous GLUCONATTRANSPORTERE
US20070202578A1 (en) * 2005-08-26 2007-08-30 Centre National De La Recherche Scientifique (Cnrs) Production of globosides oligosaccharides using metabolically engineered microorganisms
EP1991690B1 (en) 2006-03-09 2014-01-15 Centre National De La Recherche Scientifique (Cnrs) Method of producing sialylated oligosaccharides
GB0909284D0 (en) * 2009-05-29 2009-07-15 Micromass Ltd Acquisition system and method for mass spectrometer data
RU2517602C2 (ru) * 2009-06-08 2014-05-27 Йенневайн Биотехнологи Гмбх Синтез нмо
CN103764835B (zh) * 2011-06-07 2016-08-17 海罗公司 通过生物技术方法获取低聚糖
CN103060252B (zh) * 2012-12-25 2015-04-15 江南大学 一种高产乙酰氨基葡萄糖的枯草芽孢杆菌工程菌及其应用
SG10201705993YA (en) * 2013-02-11 2017-08-30 Evolva Sa Efficient production of steviol glycosides in recombinant hosts
US10364449B2 (en) * 2013-09-06 2019-07-30 Glycom A/S Fermentative production of oligosaccharides
EP2896628B1 (en) 2014-01-20 2018-09-19 Jennewein Biotechnologie GmbH Process for efficient purification of neutral human milk oligosaccharides (HMOs) from microbial fermentation
EP2905341B1 (en) * 2014-02-07 2020-04-29 Jennewein Biotechnologie GmbH Methods for producing GDP-fucose using nucleotide sugar transporters and recombinant microorganism host cells used therefor
EP2927316B1 (en) * 2014-03-31 2018-11-07 Jennewein Biotechnologie GmbH Total fermentation of oligosaccharides
EP3141610A1 (en) 2015-09-12 2017-03-15 Jennewein Biotechnologie GmbH Production of human milk oligosaccharides in microbial hosts with engineered import / export

Also Published As

Publication number Publication date
WO2017042382A1 (en) 2017-03-16
JP2024105715A (ja) 2024-08-06
RU2021135111A (ru) 2021-12-30
PH12018550020A1 (en) 2018-08-13
US12037622B2 (en) 2024-07-16
MX391225B (es) 2025-03-21
KR102700050B1 (ko) 2024-08-29
AU2016319304B2 (en) 2021-04-29
EP3141610A1 (en) 2017-03-15
RU2018109987A3 (es) 2020-01-27
JP2018526019A (ja) 2018-09-13
NZ740265A (en) 2024-10-25
NZ779656A (en) 2025-02-28
EP3347483A1 (en) 2018-07-18
CN108026556A (zh) 2018-05-11
JP2022105118A (ja) 2022-07-12
JP2022105119A (ja) 2022-07-12
JP7362831B2 (ja) 2023-10-17
US20240318216A1 (en) 2024-09-26
RU2763170C2 (ru) 2021-12-28
KR20180043297A (ko) 2018-04-27
US11046985B2 (en) 2021-06-29
JP7069007B2 (ja) 2022-05-17
AU2016319304A1 (en) 2018-03-08
MX2022003994A (es) 2022-04-26
US20180305724A1 (en) 2018-10-25
BR112018004725A2 (pt) 2018-09-25
US20210277435A1 (en) 2021-09-09
US20210277436A1 (en) 2021-09-09
RU2018109987A (ru) 2019-10-16
US12410454B2 (en) 2025-09-09
CN108026556B (zh) 2023-01-20
KR20240134049A (ko) 2024-09-05

Similar Documents

Publication Publication Date Title
MX2018003037A (es) Produccion de oligosacaridos de leche humana en huespedes microbianos con importacion/exportacion diseñada.
PH12020550039A1 (en) Sialyltransferases and their use in producing sialylated oligosaccharides
BR112017018919A8 (pt) Proteínas de fusão imunomoduladoras e seus usos
IL251188A0 (en) Central memory t cells for adoptive t cell therapy
BR112017013956B8 (pt) Proteínas de fusão de citocinas
CO2017011957A2 (es) Variantes de alfa-amilasa y polinucleótidos que codifican las mismas
BR112017014031A2 (pt) n-oligossacaril-transferase recombinante, mutante de n-oligossacaril-transferase recombinante, ácido nucleico, célula hospedeira, e, método para produção de um bioconjugado.
SI3165609T1 (sl) Ekspresijska kaseta za transformacijo evkariontske celice, postopek za transformiranje evkariontske celice, genetsko spremenjen organizem in postopek za proizvodnjo biogoriv in/ali biokemikalij ter tako proizvedena biogoriva
MX2018014043A (es) Composiciones de cultivo celular con antioxidantes y metodos para la produccion de polipeptidos.
BR112017001550A2 (pt) enxerto de tecido
MX2016013747A (es) Métodos para aislar, cultivar y diseñar genéticamente poblaciones de células inmunes para terapia adoptiva.
MX2019014009A (es) Metodos mejorados para la elaboracion de terapias celulares adoptivas.
DK3233493T3 (da) Cellulosenanofibrillær bioink til 3D-bioprintning til celledyrkning, vævsteknologi og applikationer i regenerativ medicin
MX2015013590A (es) Sistemas y metodos para la produccion dirigids de una proteina terapeutica dentro de una celula objetivo.
BR112015010283A8 (pt) bactéria gram-negativa modificada para a produção de um polissacarídeo, glicoproteína recombinante, métodos de produzir uma glicoproteína recombinante e de produzir uma vacina de gliconjugado, célula de e. coli modificada, e, vacina
MX2016011055A (es) Nuevo polisacarido y usos del mismo.
EP3472305A4 (en) MANIPULATED TREG CELLS
BR112016028512A8 (pt) método de cultivo de uma célula de mamífero e método de produção de uma proteína recombinante
BR112016015105A2 (pt) Conjugados var2csa-droga
BR112017017886A2 (pt) gerando populações de células endoteliais arteriais
BR112017011542A2 (pt) produção de ácido oleico em levedura
MX373660B (es) Fibroblastos de embrion de pollo inmortalizados.
BR112017020690A2 (pt) produção livre de células de ácido ribonucleico
BR112017013576A2 (pt) produção melhorada de lipídios de núcleo em leveduras oleaginosas
BR112013018516A2 (pt) constructo de ácido nucléico para expressão de alfa-galactosidade em plantas e células de plantas